OMERS ADMINISTRATION Corp increased its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 88.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 225,356 shares of the company's stock after buying an additional 106,066 shares during the quarter. OMERS ADMINISTRATION Corp's holdings in Procter & Gamble were worth $33,046,000 as of its most recent SEC filing.
Other hedge funds have also recently made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. increased its holdings in shares of Procter & Gamble by 1,000.0% in the fourth quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company's stock valued at $25,000 after purchasing an additional 150 shares during the period. Park Square Financial Group LLC boosted its position in Procter & Gamble by 65.1% in the fourth quarter. Park Square Financial Group LLC now owns 180 shares of the company's stock valued at $26,000 after buying an additional 71 shares during the last quarter. Evolution Wealth Management Inc. boosted its position in Procter & Gamble by 1,315.4% in the fourth quarter. Evolution Wealth Management Inc. now owns 184 shares of the company's stock valued at $26,000 after buying an additional 171 shares during the last quarter. Litman Gregory Wealth Management LLC acquired a new position in Procter & Gamble in the 4th quarter worth approximately $26,000. Finally, Mowery & Schoenfeld Wealth Management LLC acquired a new position in Procter & Gamble in the 2nd quarter worth approximately $26,000. 65.77% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In other news, CAO Matthew W. Janzaruk sold 359 shares of the firm's stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $145.24, for a total transaction of $52,141.16. Following the sale, the chief accounting officer directly owned 1,271 shares in the company, valued at $184,600.04. This trade represents a 22.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Marc S. Pritchard sold 4,030 shares of Procter & Gamble stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $143.79, for a total value of $579,473.70. Following the completion of the transaction, the insider owned 187,001 shares of the company's stock, valued at approximately $26,888,873.79. This represents a 2.11% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 6,627 shares of company stock worth $953,417 in the last ninety days. Company insiders own 0.20% of the company's stock.
Wall Street Analysts Forecast Growth
PG has been the subject of several research reports. Royal Bank Of Canada restated an "outperform" rating on shares of Procter & Gamble in a research note on Wednesday, August 19th. HSBC reissued a "hold" rating and set a $149.00 target price (down from $182.00) on shares of Procter & Gamble in a report on Thursday, July 30th. Jefferies Financial Group boosted their target price on shares of Procter & Gamble from $177.00 to $179.00 and gave the company a "buy" rating in a research report on Friday, June 26th. Argus lowered shares of Procter & Gamble from a "buy" rating to a "hold" rating in a report on Friday, August 7th. Finally, BMO Capital Markets increased their price target on Procter & Gamble from $169.00 to $170.00 and gave the stock an "outperform" rating in a research report on Monday, June 29th. Thirteen research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $161.19.
View Our Latest Research Report on PG
Procter & Gamble Price Performance
Shares of NYSE PG opened at $143.18 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.68 and a quick ratio of 0.47. The stock has a market capitalization of $332.81 billion, a price-to-earnings ratio of 21.63, a PEG ratio of 4.47 and a beta of 0.39. The firm's 50 day simple moving average is $147.25 and its 200-day simple moving average is $148.31. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $167.25.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.02. The firm had revenue of $21.20 billion during the quarter, compared to analysts' expectations of $21.38 billion. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The business's revenue was up 1.5% compared to the same quarter last year. During the same period in the previous year, the business posted $1.48 EPS. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Analysts expect that Procter & Gamble Company will post 6.98 EPS for the current year.
Procter & Gamble Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Monday, August 17th. Stockholders of record on Friday, July 24th were paid a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a dividend yield of 3.0%. The ex-dividend date of this dividend was Friday, July 24th. Procter & Gamble's dividend payout ratio is presently 65.71%.
About Procter & Gamble
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.